Verastem | VSTM - Interest Expense On Debt

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $1.15M in Interest Expense on Debt for its fiscal quarter ending in September of 2024.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Alaunos Therapeutics USD 0 0 Dec/2023
AstraZeneca USD 484M 181M Dec/2025
Curis USD 178K 441K Dec/2023
Cytokinetics USD 26.32M 2.06M Sep/2025
Gilead Sciences USD 255M 1000K Dec/2025
Incyte USD 582K 10K Dec/2025
Laboratory Of America USD 56M 1.1M Sep/2025
Novartis USD 281M 8M Sep/2025
Pfizer USD 711M 59M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
TG Therapeutics USD 6.72M 4K Sep/2025
Verastem USD 1.15M 10K Sep/2024